Search Results - Svanosio, M.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): An ongoing pharmacoeconomic study

    Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): An ongoing pharmacoeconomic study by Redaelli, A., Baldini, E., Salvadori, B., Conte, P.F., Carnino, F., Guameri, M., Svanosio, M., Dongiovanni, V.

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): an ongoing pharmacoeconomic study

    Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): an ongoing pharmacoeconomic study by Redaelli, A., Baldini, E., Salvadori, B., Aldrighetti, D., Conte, P.F., Quattrocchio, M., Svanosio, M., Bergamino, T., Tibaldi, C., Lionetto, R.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Endocrine therapy of breast cancer. The experience of the Italian Cooperative Group for Chemohormonal Therapy of Early Breast Cancer (GROCTA)

    Endocrine therapy of breast cancer. The experience of the Italian Cooperative Group for Chemohormonal Therapy of Early Breast Cancer (GROCTA) by Boccardo, F, Amoroso, D, Rubagotti, A, Sismondi, P, De Sanctis, C, Cappellini, M, Pacini, P, Castagnetta, L, Traina, A, Farris, A

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: